Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2005

01-02-2005

The Prognostic Effect of Clinical Staging in Pancreatic Adenocarcinoma

Authors: Alessio G. Morganti, MD, M. Gabriella Brizi, MD, Gabriella Macchia, MD, Giuseppina Sallustio, MD, Guido Costamagna, MD, Sergio Alfieri, MD, Gian Carlo Mattiucci, MD, Vincenzo Valentini, MD, Luigi Natale, MD, Francesco Deodato, MD, Massimiliano Mutignani, MD, G. Battista Doglietto, MD, Numa Cellini, MD

Published in: Annals of Surgical Oncology | Issue 2/2005

Login to get access

Abstract

Background

The importance of pancreatic cancer staging is uncertain. The aim of this report was to evaluate the accuracy of combined standard imaging techniques in predicting the pathologic stage and to evaluate the prognostic effect of clinical staging to identify patient groups in which laparoscopy and laparotomy could be beneficial.

Methods

Fifty-four patients were included in this analysis. The techniques used for clinical staging were endoscopic retrograde cholangiopancreatography, abdominal computed tomographic scan, and ultrasonography. All patients underwent both clinical and surgical/pathologic staging. A comparison was performed between presurgical stage and surgical/pathologic stage. The prognostic effect of different factors on survival was evaluated with both univariate (log-rank) and multivariate (Cox) analysis.

Results

Sensitivity and specificity for vascular involvement were 73.9% and 96.3%, respectively. Sensitivity and specificity for nodal involvement were 63.6% and 95.4%, respectively. A total of 33.3% of patients showed a higher than expected pathologic stage, and 3.7% showed a lower than expected pathologic stage, by comparing clinical and pathologic evaluation. A highly significant correlation was observed between clinical T stage (P = .0067) and tumor diameter (P = .0037) and patient survival. Maximal prognostic differentiation was observed by dividing patients into two groups based on imaging results: group A (favorable prognosis) and group B (unfavorable prognosis). The median survival was 25.1 and 8.0 months for group A and B, respectively. Five-year survival was 20.1% and 0%, respectively (multivariate analysis: P = .0007).

Conclusions

Integrated standard imaging studies achieved reasonable diagnostic accuracy in our analysis. A single classification based on clinical stage and tumor diameter evaluated by imaging predicts prognosis in patients with pancreatic carcinoma.
Literature
1.
Jimenez, RE, Warshaw, AL, Rattner, DW, Willett, CG, McGrath, D, Fernandez-del Castillo, C 2000Impact of laparoscopic staging in the treatment of pancreatic cancerArch Surg13540914PubMed
2.
Saldinger, PF, Reilly, M, Reynolds, K,  et al. 2000Is CT angiography sufficient for prediction of resectability of periampullary neoplasms?J Gastrointest Surg42337CrossRefPubMed
3.
Spitz, FR, Abruzzese, JL, Lee, JE,  et al. 1997Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreasJ Clin Oncol1592837PubMed
4.
Wanebo, HJ, Glicksmann, AS, Vezeridis, MP,  et al. 2000Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancerArch Surg135817CrossRefPubMed
5.
Snady, H, Bruckner, H, Cooperman, A, Paradiso, J, Kiefer, L 2000Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma An outcomes trialCancer8931427CrossRefPubMed
6.
Kamthan, AG, Morris, JC, Dalton, J,  et al. 1997Combined modality therapy for stage II and stage III pancreatic carcinomaJ Clin Oncol1529207PubMed
7.
Delcore, R, Rodriguez, FJ, Forster, J, Hermreck, AS, Thomas, JH 1996Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resectionAm J Surg1724638PubMed
8.
Tannapfel, A, Wittekind, C, Hunefeld, G 1992Ductal adenocarcinoma of the pancreas. Histopathological features and prognosisInt J Pancreatol1214552PubMed
9.
Gorelick, AB, Scheiman, JM, Fendrick, AM 1998Identification of patients with resectable pancreatic cancer: at what stage are we?Am J Gastroenterol9319956PubMed
10.
Midwinter, MJ, Beveridge, CJ, Wilsdon, JB, Bennett, MK, Baudouin, CJ, Charnley, RM 1999Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumoursBr J Surg8618993PubMed
11.
Fishman, EK, Horton, KM, Urban, BA 2000Multidetector CT angiography in the evaluation of pancreatic carcinoma: preliminary observationsJ Comput Assist Tomogr2484953PubMed
12.
Tierney, WM, Francis, IR, Eckhauser, F, Elta, G, Nostrant, TT, Scheiman, JM 2001The accuracy of EUS and helical CT in the assessment of vascular invasion by periampullary malignancyGastrointest Endosc531828PubMed
13.
14.
Mertz, HR, Sechopoulos, P, Delbeke, D, Leach, SD 2000EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinomaGastrointest Endosc5236771CrossRefPubMed
15.
Diederichs, CG, Staib, L, Vogel, J,  et al. 2000Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic massesPancreas2010916CrossRefPubMed
16.
Minnard, EA, Conlon, KC, Hoos, A, Dougherty, EC, Hann, LE, Brennan, MF 1998Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancerAnn Surg2281827PubMed
17.
Fernandez-del Castillo, CL, Warshaw, AL 1998Pancreatic cancer. Laparoscopic staging and peritoneal cytologySurg Oncol Clin North Am713542
18.
Bottger, TC, Boddin, J, Duber, C, Heintz, A, Kuchle, R, Junginger, T 1998Diagnosing and staging of pancreatic carcinoma—what is necessary?Oncology551229PubMed
19.
Marano, P, Brizi, MG, Cellini, N,  et al. 1993Diagnostic and therapeutic integration in ductal carcinoma of the head of the pancreas. Preliminary noteRadiol Med8561524PubMed
20.
Montemaggi, P, Dobelbower, R,Jr, Crucitti, F,  et al. 1991Interstitial brachytherapy for pancreatic cancer: report of seven cases treated with 125-I and a review of the literatureInt J Radiat Oncol Biol Phys214517PubMed
21.
Crucitti, F, Doglietto, GB, Frontera, D,  et al. 1998Integrated radiosurgical treatment of resectable pancreatic head carcinomaPancreas16319PubMed
22.
Morganti, AG, Valentini, V, Macchia, G,  et al. 20045-FU-based chemoradiation in unresectable pancreatic carcinoma: a phase II dose escalation studyInt J Radiat Oncol Biol Phys54145460
23.
Exocrine pancreas. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th ed. Lippincott-Raven, Philadelphia, 1997; pp 121–6.
24.
Kaplan, FL, Meier, P 1958Nonparametric estimation from incomplete observationsAm J Stat Assoc5345781
25.
Peto, R, Peto, J 1972Asymptotically efficient rank invariant proceduresJ R Stat Soc135185207CrossRef
26.
Cox, DR 1972Regression model and life tablesJ R Stat Soc B34187220
27.
Sheridan, MB, Ward, J, Guthrie, JA,  et al. 1999Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparison study with receiver operating characteristics analysisAJR Am J Roentgenol1735839PubMed
28.
Tomazic, A, Pegan, V 2000Preoperative staging of periampullar cancer with US, CT, EUS and Ca19-9Hepatogastroenterology4711357PubMed
29.
Riker, A, Libutti, SK, Bartlett, DL 1997Advances in the early detection, diagnosis, and staging of pancreatic cancerSurg Oncol615769PubMed
Metadata
Title
The Prognostic Effect of Clinical Staging in Pancreatic Adenocarcinoma
Authors
Alessio G. Morganti, MD
M. Gabriella Brizi, MD
Gabriella Macchia, MD
Giuseppina Sallustio, MD
Guido Costamagna, MD
Sergio Alfieri, MD
Gian Carlo Mattiucci, MD
Vincenzo Valentini, MD
Luigi Natale, MD
Francesco Deodato, MD
Massimiliano Mutignani, MD
G. Battista Doglietto, MD
Numa Cellini, MD
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2005
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2005.02.021

Other articles of this Issue 2/2005

Annals of Surgical Oncology 2/2005 Go to the issue

Editorial

Pelvic Reconstruction After Abdominoperineal Resection: Is It Worthwhile?

Original Article

Isolated Hepatic Perfusion for the Treatment of Patients With Colorectal Cancer Liver Metastases After Irinotecan-Based Therapy

OriginalPaper

Intraoperative Subareolar Injection of 99mTc-Labeled Sulfur Colloid Results in Consistent Sentinel Lymph Node Identification

OriginalPaper

Prospective Evaluation of Quality of Life of Patients Receiving Either Abdominoperineal Resection or Sphincter-Preserving Procedure for Rectal Cancer

OriginalPaper

Electrical Impedance Scanning of Thyroid Nodules Before Thyroid Surgery: A Prospective Study

Editorial

Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Plea for Prospective Differentiation Between Main-Duct and Side-Branch Tumors